These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8259376

  • 1. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N, Sakaguchi K, Fujitani B, Aishita H.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G, Seipp U.
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [Abstract] [Full Text] [Related]

  • 7. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets.
    Mastacchi R, Barbanti M, Bianchini P, Osima B.
    Agents Actions; 1986 Mar; 17(5-6):512-4. PubMed ID: 3518359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.
    Nishio S, Matsuura H, Kanai N, Fukatsu Y, Hirano T, Nishikawa N, Kameoka K, Umetsu T.
    Jpn J Pharmacol; 1988 May; 47(1):1-10. PubMed ID: 2842529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B, Wakitani K.
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y, Sato K, Shigenaga T, Hisamichi N, Ichihara M, Akamatsu S, Suzuki Ki, Nii T, Kaku S, Kawasaki T, Matsumoto Y, Inagaki O, Tomioka K, Yanagisawa I.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):43-52. PubMed ID: 11937091
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K, Someya K, Tachiiri T, Mitsuoka Y, Nakamura K, Imai S, Ino T, Ohkubo H.
    Arzneimittelforschung; 1992 Jan 29; 42(1):32-9. PubMed ID: 1586377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.